Why Revolution Medicines (RVMD) Stock Fell 4.33% in 10 Minutes After Q3 Earnings on Nov 4, 2026
EPS of -$1.90 came in above the -$2.42 estimate.
- RVMD fell 4.33% in the 10 minutes after the 16:04:58 ET headline, from $222.66 to $213.01.
- The 4.33% drop was larger than any reaction MoveSurge measured after Revolution Medicines headlines between Aug 6, 2026 and Nov 3, 2026; the largest of those was +0.54% in 15 minutes, on Aug 27, 2026.
- 36,650 shares changed hands in those 10 minutes.
16:04:58 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| RVMD | 222.66 | 222.66 | 219.99 | 213.01 | -1.20% | -4.33% |
Revolution Medicines (RVMD) shares fell 4.33% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:04:58 ET on Wednesday, November 4, 2026. EPS of -$1.90 came in above the -$2.42 estimate.
RVMD in the first 10 minutes
The line that crossed at 16:04:58 ET: “RVMD Q3: EPS -1.9 vs -2.42 est”
From a reference price of $222.66 just before the headline, the stock was down 1.20% after one minute and down 4.33%, at $213.01, after 10 minutes. The move kept building after the first minute. 36,650 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 4 minutes after the 4:00 ET close.
Revolution Medicines Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| EPS | -$1.90 | -$2.42 | Beat |
How RVMD traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 5, 2026 | -3.06 vs -1.98 | — | not measured |
Earlier RVMD headlines and the measured reaction
The 4.33% drop was larger than any reaction MoveSurge measured after Revolution Medicines headlines between Aug 6, 2026 and Nov 3, 2026; the largest of those was +0.54% in 15 minutes, on Aug 27, 2026.
- Aug 27, 2026, 11:08 ET: “Revolution Medicines’ Pancreatic Cancer Drug Approval Confirms Microcap Propanc Biopharma’s Breakthrough Survival Results” (+0.54% in 15 minutes)
Revolution Medicines at a glance
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Market value | $41.63 billion (as of Nov 4, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Revolution Medicines stock react to its Q3 earnings on November 4, 2026?
The stock fell 4.33% in the 10 minutes after its Q3 results crossed at 16:04:58 ET. EPS of -$1.90 came in above the -$2.42 estimate.
How far did RVMD move after the headline?
From $222.66 just before the headline to $213.01 10 minutes later, a -4.33% move.
Sources
-
RVMD headline and measured reaction, Nov 4, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free